<DOC>
	<DOCNO>NCT01947816</DOCNO>
	<brief_summary>This investigation conduct obtain follow information regard use Humira 40mg Syringe 0.8mL Subcutaneous Injection patient Ulcerative Colitis . 1 . Unknown adverse reaction ( particular , clinically significant ) 2 . Incidence condition occurrence adverse reaction clinical practice 3 . Factors likely affect safety effectiveness</brief_summary>
	<brief_title>Special Investigation Patients With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Patients receive Humira first time treatment Ulcerative Colitis Contraindications accord Package Insert include patient follow : serious infection tuberculosis history hypersensitivity ingredient Humira demyelinate disease history demyelinate disease congestive cardiac failure</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Ulcerative Colitis</keyword>
</DOC>